A VS HLN Stock Comparison

Performance

A
29/100

A returned -20.34% in the last 12 months. Based on SPY's performance of -16.79%, its performance is below average giving it a score of 28 of 100.

HLN
100/100

HLN returned 20.18% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

A
82/100

14 analysts offer 12-month price targets for A. Together, they have an average target of 167.75, the most optimistic target put A at 170 within 12-months and the most pessimistic has A at 161.

HLN

"Analyst Price Targets" not found for HLN

Sentiment

A
69/100

A had a bullish sentiment score of 69.50% across Twitter and StockTwits over the last 12 months. It had an average of 77.66 posts, 409.66 comments, and 1,364.19 likes per day.

HLN

"Sentiment" not found for HLN

Technicals

A
50/100

A receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

HLN
50/100

HLN receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

Earnings

A
100/100

A has missed earnings 0 times in the last 20 quarters.

HLN
100/100

HLN has missed earnings 1 times in the last 20 quarters.

Profit

A
79/100

Out of the last 20 quarters, A has had 20 profitable quarters and has increased their profits year over year on 10 of them.

HLN
72/100

Out of the last 9 quarters, HLN has had 9 profitable quarters and has increased their profits year over year on 3 of them.

Volatility

A
52/100

A has had a higher than average amount of volatility over the last 12 months giving it a score of 51 of 100.

HLN
57/100

HLN has had a higher than average amount of volatility over the last 12 months giving it a score of 57 of 100.

Dividend

A
48/100

A's most recent dividend was $0.15 per share, based on a share price of $109.02. It was a payout ratio of 24.10% compared to their total earnings.

HLN

"Dividend" not found for HLN

All score calculations are broken down here to help you make more informed investing decisions

Agilent Technologies Inc. Summary

New York Stock Exchange / A

Healthcare

Medical - Diagnostics & Research

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) Summary

New York Stock Exchange / HLN

Healthcare

Drug Manufacturers - Specialty & Generic

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Power up your portfolio